34 A. Mode d'action et pharmacodynamique, 35 E. Contre-indications, p.35 ,
Bleeding Academic Research Consortium Débit de Filtration Glycoprotéine 2b Héparine de Bas Poids Moléculaire Percutaneous Coronary Intervention, Service Mobile d'Urgence et de Réanimation ? SCA ............... Syndrome Coronarien Aigu ? ST+ ............... Sus-décalage du segment ST sur l'électrocardiogramme Bibliographie [1] Longeaux N and Azema O. Rapport annuel 2011 sur l'activité des structures d'urgences en midi-pyrénées, 2011. ,
??pid??miologie des syndromes coronaires aigus en France et en Europe, Annales de Cardiologie et d'Ang??iologie, vol.59, issue.2, pp.37-41, 2010. ,
DOI : 10.1016/S0003-3928(10)70008-1
AHA guideline for the management of ST-elevation myocardial infarction, ACCF J AM Health Association, vol.127, issue.4, pp.362-425, 2013. ,
Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials, The Lancet, vol.367, issue.9510, pp.367579-88, 2006. ,
DOI : 10.1016/S0140-6736(06)68148-8
Bivalirudin Started during Emergency Transport for Primary PCI, New England Journal of Medicine, vol.369, issue.23, pp.2207-2224, 2013. ,
DOI : 10.1056/NEJMoa1311096
Bivalirudin is superior to heparins alone with bailout GP IIb/IIIa inhibitors in patients with ST-segment elevation myocardial infarction transported emergently for primary percutaneous coronary intervention: a pre-specified analysis from the EUROMAX trial, European Heart Journal, vol.378, issue.9792, pp.352460-352467, 2014. ,
DOI : 10.1016/S0140-6736(11)60876-3
Bivalirudin during Primary PCI in Acute Myocardial Infarction, New England Journal of Medicine, vol.358, issue.21, pp.2218-2230, 2008. ,
DOI : 10.1056/NEJMoa0708191
Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial, The Lancet, vol.377, issue.9784, pp.3772193-204, 2011. ,
DOI : 10.1016/S0140-6736(11)60764-2
Heart Disease and Stroke Statistics--2014 Update: A Report From the American Heart Association, Circulation, vol.129, issue.3, pp.28-292, 2014. ,
DOI : 10.1161/01.cir.0000441139.02102.80
French Registry on Acute ST-elevation and non ST-elevation Myocardial Infarction 2010. FAST-MI 2010, Heart, vol.98, issue.9, pp.98699-705, 2012. ,
DOI : 10.1136/heartjnl-2012-301700
Association of Changes in Clinical Characteristics and Management With Improvement in Survival Among Patients With ST-Elevation Myocardial Infarction, JAMA, vol.308, issue.10, pp.998-1006, 2012. ,
DOI : 10.1001/2012.jama.11348
Conférence de l'ESC 2012, FAST-MI. STEMI : la mortalité diminue grâce à une meilleure prise en charge globale ,
MONitoring of trends and determinants in CArdiovascular disease ,
Athérome : anatomie pathologique, épidémiologie, facteur de risque et prévention (page consultée le 11, 2015. ,
Bivalirudin Is a Dual Inhibitor of Thrombin and Collagen-Dependent Platelet Activation in Patients Undergoing Percutaneous Coronary Intervention, Circulation: Cardiovascular Interventions, vol.4, issue.2, pp.171-180, 2011. ,
DOI : 10.1161/CIRCINTERVENTIONS.110.959098
Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: Study design and rationale, American Heart Journal, vol.148, issue.5, pp.764-75, 2004. ,
DOI : 10.1016/j.ahj.2004.04.036
Use of Bivalirudin During Percutaneous Coronary Intervention in Patients With Diabetes Mellitus, Journal of the American College of Cardiology, vol.45, issue.12, pp.451932-451940, 2005. ,
DOI : 10.1016/j.jacc.2005.02.074
Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial, The Lancet, vol.378, issue.9792, pp.378693-703, 2011. ,
DOI : 10.1016/S0140-6736(11)60876-3
Bivalirudin for Patients with Acute Coronary Syndromes, New England Journal of Medicine, vol.355, issue.21, pp.2203-2219, 2006. ,
DOI : 10.1056/NEJMoa062437
Comparison of Prasugrel and Bivalirudin vs Clopidogrel and Heparin in Patients With ST-Segment Elevation Myocardial Infarction: Design and Rationale of the Bavarian Reperfusion Alternatives Evaluation (BRAVE) 4 Trial, Clinical Cardiology, vol.116, issue.5, pp.270-276, 2014. ,
DOI : 10.1161/CIRCULATIONAHA.107.187397
Prasugrel and bivalirudin for primary angioplasty: Early results on stent thrombosis and bleeding, International Journal of Cardiology, vol.153, issue.2, pp.222-226, 2011. ,
DOI : 10.1016/j.ijcard.2011.09.059
A comparative study of bivalirudin plus clopidogrel versus bivalirudin plus prasugrel in primary angioplasty using propensity score matching, J Interv Cardiol, vol.26, issue.5, pp.463-472, 2013. ,
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes, New England Journal of Medicine, vol.357, issue.20, pp.2001-2016, 2007. ,
DOI : 10.1056/NEJMoa0706482
Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial, The Lancet, vol.373, issue.9665, pp.373723-373754, 2009. ,
DOI : 10.1016/S0140-6736(09)60441-4
Feasibility and Safety of Prehospital Administration of Bivalirudin in Patients With ST-Elevation Myocardial Infarction, The American Journal of Cardiology, vol.103, issue.12, pp.1635-1675, 2009. ,
DOI : 10.1016/j.amjcard.2009.02.015
Safety and effectiveness of bivalirudin in routine care of patients undergoing percutaneous coronary intervention, European Heart Journal, vol.115, issue.9, pp.561-72, 2010. ,
DOI : 10.1016/j.amjmed.2003.08.025
Traitement pr??hospitalier par bivalirudine de l???infarctus aigu du myocarde orient?? vers une angioplastie primaire. ?? propos d???une s??rie cons??cutive de 152??cas, Annales de Cardiologie et d'Ang??iologie, vol.62, issue.4, pp.227-259, 2013. ,
DOI : 10.1016/j.ancard.2013.03.005
Bivalirudine en préhospitalier dans l'angioplastie primaire : expérience du chu de nancy et comparaison avec une population traitée par abciximab, 2013. ,
The ideal anticoagulation strategy in ST-elevation myocardial infarction Publié en ligne, Prog Cardiovasc Dis, vol.15, pp.33-062000066 ,
Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial, The Lancet, vol.384, issue.9957, pp.3841849-58, 2014. ,
DOI : 10.1016/S0140-6736(14)60924-7
Bivalirudin in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: outcomes in a large real-world population, EuroIntervention, vol.9, issue.1, pp.118-142, 2013. ,
DOI : 10.4244/EIJV9I1A17
Bivalirudin versus heparin and heparin plus tirofiban in patients with AMI undergoing PCI, JAMA, issue.13, pp.3131336-3131382, 2015. ,
Bivalirudin in percutaneous coronary intervention: The EUROpean BiValIrudin UtiliSatION in Practice (EUROVISION) Registry, International Journal of Cardiology, vol.173, issue.2, pp.290-294, 2014. ,
DOI : 10.1016/j.ijcard.2014.03.003
Bivalirudin is associated with improved clinical and economic outcomes in heart failure patients undergoing percutaneous coronary intervention: Results from an observational database, Catheterization and Cardiovascular Interventions, vol.384, issue.3, 2015. ,
DOI : 10.1016/S0140-6736(14)60924-7
Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes, New England Journal of Medicine, vol.373, issue.11, pp.997-1009, 2015. ,
DOI : 10.1056/NEJMoa1507854
URL : https://boris.unibe.ch/71500/1/Valgimigli%20NEnglJMed%202015.pdf